Epirubicin plus Cyclophosphamide: Clinical Trials

1 trial of Epirubicin plus Cyclophosphamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow Epirubicin plus Cyclophosphamide: new trials by email Literature Review of Epirubicin plus Cyclophosphamide trials Research Report on Epirubicin plus Cyclophosphamide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer
Epirubicin plus Cyclophosphamide, Taxanes, Taxanes plus Carboplatin - Breast Neoplasm
Phase 3Active not recruitingShanghai Jiao Tong University School of Medicine7862016-03-012025-07-11

Conditions studied

Breast Neoplasms (1)

Sponsors

Shanghai Jiao Tong University School of Medicine (1)

Countries

China (1)

Top investigators

Kunwei Shen, professor (1)

Results publications

PMID 41365333